Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 137,764 | 137,162 | -32,915 | -27,518 | -36,345 |
| Depreciation Amortization | 4,905 | 3,154 | 8,008 | 6,036 | 4,064 |
| Accounts receivable | -6,482 | 4,761 | -19,341 | -7,582 | -5,167 |
| Other Working Capital | 2,150 | 55,788 | -25,096 | -14,291 | -9,758 |
| Other Operating Activity | 6,237 | 2,986 | 3,567 | -9,878 | 83 |
| Operating Cash Flow | $144,574 | $203,851 | $-65,777 | $-53,233 | $-47,123 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -79 | N/A | 1,165 | 1,165 | 1,165 |
| Net Acquisitions | N/A | N/A | 8,956 | 8,956 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 6,086 |
| Investing Cash Flow | $-79 | $N/A | $10,121 | $10,121 | $7,251 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | -75 | -130 | N/A |
| Debt Repayment | -14,494 | N/A | -5,561 | -5,506 | -4,932 |
| Common Stock Issued | 1,670 | 1,438 | 3,959 | 2,539 | 56,077 |
| Dividend Paid | N/A | N/A | -664 | -498 | -332 |
| Other Financing Activity | -14,476 | -28,829 | 79,783 | 75,330 | 5,850 |
| Financing Cash Flow | $-27,300 | $-27,391 | $77,442 | $71,735 | $56,663 |
| Beginning Cash Position | 80,601 | 80,601 | 58,815 | 58,815 | 58,815 |
| End Cash Position | 197,796 | 257,061 | 80,601 | 87,438 | 75,606 |
| Net Cash Flow | $117,195 | $176,460 | $21,786 | $28,623 | $16,791 |
| Free Cash Flow | |||||
| Operating Cash Flow | 144,574 | 203,851 | -65,777 | -53,233 | -47,123 |
| Capital Expenditure | -79 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 144,495 | 203,851 | -65,777 | -53,233 | -47,123 |